Ortho Pediatrics Corp - Understand $kids stock

$KIDS Market Cap: $622.8 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$189.7M

TTM

Gross Margin

73.43%

TTM

Net Earnings

-$28.44M

TTM

Current Assets

$248.3M

Q3 2024

Current Liabilities

$34.63M

Q3 2024

Current Ratio

717.15%

Q3 2024

Total Assets

$489.3M

Q3 2024

Total Liabilities

$118.4M

Q3 2024

Book Value

$370.9M

Q3 2024

Cash

$51.05M

Q3 2024

P/E

-21.90

Nov 08, 2024 EST

Free Cash Flow

-$51.07M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$148.7M	$122.3M	$98.05M	$71.08M	$72.55M	$57.56M	$45.62M	$37.30M	$31.00M	$23.68M
YoY Change	21.62%	24.72%	37.95%	-2.03%	26.05%	26.17%	22.31%	20.3%	30.93%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$148.7M	$122.3M	$98.05M	$71.08M	$72.55M	$57.56M	$45.62M	$37.30M	$31.00M	$23.68M
Cost Of Revenue	$37.48M	$31.63M	$24.65M	$16.05M	$17.93M	$14.88M	$11.17M	$10.93M	$9.367M	$7.090M
Gross Profit	$111.3M	$90.66M	$73.40M	$55.03M	$54.62M	$42.68M	$34.45M	$26.37M	$21.64M	$16.60M
Gross Profit Margin	74.8%	74.14%	74.86%	77.42%	75.28%	74.15%	75.52%	70.69%	69.79%	70.1%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Selling, General & Admin	$126.8M	$104.4M	$85.73M	$70.17M	$57.95M	$47.50M	$37.50M	$28.29M	$26.44M	$22.06M
YoY Change	21.44%	21.81%	22.18%	21.09%	21.99%	26.67%	32.54%	7.0%	19.85%
% of Gross Profit	114.0%	115.2%	116.8%	127.51%	106.09%	111.3%	108.85%	107.3%	122.2%	132.89%
Research & Development	$10.20M	$8.014M	$5.543M	$5.273M	$5.748M	$4.732M	$3.423M	$2.223M	$1.789M	$1.680M
YoY Change	27.23%	44.58%	5.12%	-8.26%	21.47%	38.24%	53.98%	24.26%	6.49%
% of Gross Profit	9.16%	8.84%	7.55%	9.58%	10.52%	11.09%	9.94%	8.43%	8.27%	10.12%
Depreciation & Amortization	$17.39M	$13.10M	$10.68M	$8.010M	$4.671M	$2.892M	$2.405M	$1.902M	$1.854M	$1.580M
YoY Change	32.72%	22.65%	33.33%	71.48%	61.51%	20.25%	26.45%	2.59%	17.34%
% of Gross Profit	15.63%	14.45%	14.55%	14.56%	8.55%	6.78%	6.98%	7.21%	8.57%	9.52%
Operating Expenses	$138.0M	$116.1M	$91.43M	$81.79M	$63.70M	$52.23M	$40.92M	$32.49M	$28.23M	$23.74M
YoY Change	18.91%	26.94%	11.79%	28.4%	21.95%	27.64%	25.94%	15.11%	18.91%
Operating Profit	-$26.75M	-$25.40M	-$18.02M	-$26.76M	-$9.077M	-$9.553M	-$6.472M	-$6.127M	-$6.592M	-$7.140M
YoY Change	5.32%	40.92%	-32.63%	194.76%	-4.98%	47.61%	5.63%	-7.05%	-7.68%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Interest Expense	$3.178M	$23.51M	-$447.0K	$3.412M	$3.538M	$2.255M	$2.490M	$1.476M	$1.230M	-$2.550M
YoY Change	-86.48%	-5358.61%	-113.1%	-3.56%	56.9%	-9.44%	68.7%	20.0%	-148.24%
% of Operating Profit
Other Income/Expense, Net	$5.439M	$21.71M	$636.0K	-$6.912M	-$3.608M	-$2.472M	-$2.460M	-$445.0K	-$1.261M	-$70.00K
YoY Change	-74.95%	3313.52%	-109.2%	91.57%	45.95%	0.49%	452.81%	-64.71%	1701.43%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Pretax Income	-$21.31M	-$3.689M	-$17.39M	-$33.67M	-$12.69M	-$11.77M	-$8.803M	-$6.570M	-$7.850M	-$9.760M
YoY Change	477.72%	-78.78%	-48.35%	165.41%	7.79%	33.68%	33.99%	-16.31%	-19.57%
Income Tax	-$338.0K	-$4.947M	-$1.128M	-$723.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$20.97M	$1.258M	-$16.26M	-$32.94M	-$13.73M	-$12.03M	-$8.932M	-$6.572M	-$7.891M	-$9.550M
YoY Change	-1767.25%	-107.74%	-50.64%	139.92%	14.19%	34.63%	35.91%	-16.72%	-17.37%
Net Earnings / Revenue	-14.1%	1.03%	-16.58%	-46.35%	-18.93%	-20.89%	-19.58%	-17.62%	-25.45%	-40.33%
Basic Earnings Per Share	-$0.92	$0.06	-$0.84	-$1.82	-$0.94
Diluted Earnings Per Share	-$0.92	$0.06	-$0.84	-$1.82	-$0.94	-$957.0K	-$699.3K	-$545.7K	-$655.3K	-$793.2K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Short-Term Investments	$80.31M	$118.3M	$53.54M	$83.90M	$70.80M	$60.70M	$42.60M	$1.600M	$3.900M	$6.600M
YoY Change	-32.11%	120.93%	-36.18%	18.5%	16.64%	42.49%	2562.5%	-58.97%	-40.91%
Cash & Equivalents	$49.25M	$109.3M	$45.90M	$55.10M
Short-Term Investments
Other Short-Term Assets	$5.722M	$5.437M	$4.594M	$4.000M	$2.800M	$1.300M	$800.0K	$200.0K	$200.0K	$900.0K
YoY Change	5.24%	18.35%	14.85%	42.86%	115.38%	62.5%	300.0%	0.0%	-77.78%
Inventory	$105.9M	$78.19M	$57.57M	$53.00M	$38.00M	$25.70M	$20.50M	$14.90M	$14.60M	$17.30M
Prepaid Expenses
Receivables	$34.62M	$24.80M	$17.94M	$17.20M	$16.00M	$9.000M	$5.600M	$4.100M	$3.800M	$2.800M
Other Receivables	$0.00	$0.00	$0.00	$300.0K	$600.0K	$500.0K	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$226.5M	$226.7M	$133.6M	$158.4M	$128.1M	$97.20M	$69.60M	$20.80M	$22.50M	$27.50M
YoY Change	-0.1%	69.64%	-15.63%	23.65%	31.79%	39.66%	234.62%	-7.56%	-18.18%
Property, Plant & Equipment	$41.05M	$34.29M	$28.52M	$27.20M	$21.30M	$12.80M	$10.40M	$8.600M	$7.300M	$7.500M
YoY Change	19.72%	20.24%	4.83%	27.7%	66.41%	23.08%	20.93%	17.81%	-2.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.940M
YoY Change
Total Long-Term Assets	$212.2M	$201.0M	$170.6M	$162.0M	$54.10M	$14.90M	$12.70M	$9.900M	$8.200M	$8.300M
YoY Change	5.59%	17.81%	5.32%	199.45%	263.09%	17.32%	28.28%	20.73%	-1.2%
Total Assets	$438.7M	$427.7M	$304.3M	$320.4M	$182.2M	$112.1M	$82.30M	$30.70M	$30.70M	$35.80M
YoY Change
Accounts Payable	$12.65M	$11.15M	$9.325M	$10.00M	$6.500M	$4.000M	$5.500M	$3.500M	$2.000M	$600.0K
YoY Change	13.44%	19.57%	-6.75%	53.85%	62.5%	-27.27%	57.14%	75.0%	233.33%
Accrued Expenses	$11.33M	$6.744M	$5.351M	$10.90M	$4.300M	$3.600M	$2.900M	$2.200M	$2.300M	$1.500M
YoY Change	67.93%	26.03%	-50.91%	153.49%	19.44%	24.14%	31.82%	-4.35%	53.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$152.0K	$144.0K	$137.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K
YoY Change	5.56%	5.11%	37.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Total Short-Term Liabilities	$41.67M	$30.87M	$29.72M	$35.00M	$13.70M	$9.200M	$9.500M	$7.300M	$6.300M	$3.200M
YoY Change	34.97%	3.89%	-15.1%	155.47%	48.91%	-3.16%	30.14%	15.87%	96.88%
Long-Term Debt	$9.908M	$763.0K	$907.0K	$1.000M	$26.10M	$21.20M	$25.30M	$17.40M	$13.00M	$14.60M
YoY Change	1198.56%	-15.88%	-9.3%	-96.17%	23.11%	-16.21%	45.4%	33.85%	-10.96%
Other Long-Term Liabilities	$4.663M	$11.49M	$43.51M	$43.80M	$100.0K
YoY Change	-59.42%	-73.59%	-0.66%	43700.0%
Total Long-Term Liabilities	$14.57M	$12.25M	$44.42M	$44.80M	$26.20M	$21.20M	$25.30M	$17.40M	$13.00M	$14.60M
YoY Change	18.91%	-72.41%	-0.85%	70.99%	23.58%	-16.21%	45.4%	33.85%	-10.96%
Total Liabilities	$61.72M	$49.08M	$78.91M	$85.60M	$39.80M	$30.40M	$34.80M	$24.70M	$19.40M	$17.90M
YoY Change	25.76%	-37.8%	-7.82%	115.08%	30.92%	-12.64%	40.89%	27.32%	8.38%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019
Basic Shares Outstanding	22.68M shares	20.70M shares	19.27M shares	18.06M shares	14.62M shares
Diluted Shares Outstanding	22.68M shares	20.95M shares	19.27M shares	18.06M shares	14.62M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $622.8 Million

About OrthoPediatrics Corp

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. The company is headquartered in Warsaw Indiana, Indiana and currently employs 247 full-time employees. The company went IPO on 2017-10-12. The firm is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The firm sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. The company markets 53 surgical and specialized bracing systems.

Industry: Surgical & Medical Instruments & Apparatus Peers: ATRION CORP Avanos Medical Inc BioLife Solutions Inc Cerus Corp Figs Inc MERIDIAN BIOSCIENCE INC Pulmonx Corp Silk Road Medical Inc UFP Technologies Inc